UPCOMING SESSIONS in ET
Wed, Apr 15, 2026
3:00 – 5:00 PM UTC
Newly Diagnosed ATTR Patients Onboarding Session Dr. Stacey Goodman Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 15, 2026 · 3:00 – 5:00 PM UTC
Newly Diagnosed ATTR Patients Onboarding Session
Dr. Stacey Goodman
Click To Register
View all sessions

NICE (UK) positive for Beyonttra (acoramidis) for treating transthyretin amyloidosis with cardiomyopathy – Bayer

Published: Apr 02, 2026
Category
News
Source
Medical Update Online

NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.

Acoramidis can only be used if the company provides it according to the commercial arrangement.

News Url
Read More